<DOC>
	<DOCNO>NCT00104091</DOCNO>
	<brief_summary>Immunotoxin therapy may effective treat malignant glioma . Immunotoxins locate tumor cell kill without harm normal cell .</brief_summary>
	<brief_title>Safety Efficacy Study Treat Recurrent Grade 4 Malignant Brain Tumors</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>The patient must fulfill follow criterion : Previous histologicallyconfirmed diagnosis primary GBM ( glioblastoma multiforme , glioma grade 4 time first diagnosis ) . Histologicallyconfirmed MRI diagnose recurrent progressive GBM previous resection ( surgical biopsy ) radiation therapy . Medically capable undergoing plan surgical gross total resection catheter placement . Age ≥ 18 . Karnofsky Performance Status ≥ 70 % . Life expectancy ≥ 3 month . Patients must already take begin take corticosteroid stable dose 4 mg every 6 hour least 72 hour prior catheter placement . Patients must capable take , already take , anticonvulsant medication . Patients must read , sign , date informed consent accord ICHGCP , local regulatory requirement rule follow institution . Patients fulfil follow criterion enrol study : Previous myelosuppressive chemotherapy within past 4 week start infusion . Patients receive two chemotherapy regimen ( single therapy combination therapy ) ineligible . Any form brain radiation within 10 week start infusion . Previous gamma knife radiosurgery , stereotactic radiosurgery , and/or internal radiotherapy , unless recurrence/progression histologically confirm ( fineneedle biopsy ) . Prior intracavitary biologic response modifier monoclonal antibody . Uncontrolled seizure . Bilateral multifocal tumor . Evidence cerebral uncal herniation . Midline brain shift MRI scan &gt; 0.5 cm prior resection ; patient subfalcine herniation may enrol . Tumors involve brainstem cerebellum . Diffuse subependymal CSF disease . Women pregnant breast feeding . All woman childbearing potential excluded unless negative pregnancy test use adequate contraceptive measure surgically sterile . Postmenopausal woman must amenorrheic least 12 month consider nonchildbearing . Fertile male practice adequate contraception whose female partner use adequate contraceptive protection . Prior concurrent investigational treatment within 30 day study entry . Active infection require treatment unexplained febrile illness . Systemic disease condition may associate unacceptable anesthetic/operative risk and/or would allow safe completion study protocol . Prior concurrent malignancy ( curatively treat carcinomainsitu basal cell carcinoma patient disease free least 5 year eligible ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Gross Total Resection</keyword>
	<keyword>Convection Enhanced Delivery</keyword>
	<keyword>Recurrent Glioblastoma Multiforme</keyword>
</DOC>